Document Detail

Natriuretic effect of barnidipine, a long-acting dihydropyridine calcium channel blocker, in patients with essential hypertension.
MedLine Citation:
PMID:  10890579     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: To evaluate the effect of barnidipine hydrochloride, a long-acting dihydropyridine calcium channel blocker on urinary sodium excretion in patients with essential hypertension. PATIENTS: Twelve patients (2 males, 10 females) with mild to moderate essential hypertension. METHODS: A single-blinded study. After the control (placebo) period, 10 to 15 mg barnidipine hydrochloride was administered for 7 days, followed by a post-treatment (placebo) period. Daily changes in blood pressure, urinary volume, and urinary electrolyte excretions were evaluated. Plasma levels of atrial natriuretic peptide (ANP) and aldosterone were also determined in each period. Daily sodium intake was kept at 120 mEq. RESULTS: Blood pressure decreased from 161 +/- 4/92 +/- 2 mmHg to 146 +/- 4/85 +/- 2 mmHg (p<0.05) after 7-day-treatment with barnidipine. Barnidipine significantly increased urinary sodium excretion; the change was evident on the first day of administration (control period 41 +/- 3 mEq/day, and first day 59 +/- 3 mEq/day, p < 0.05). Drug discontinuation transiently decreased sodium excretion to 35 +/- 3 mEq/day. Cumulative sodium balance after 7-day-treatment reached 47 +/- 19 mEq. Urine volume, potassium excretion, and creatinine excretion did not change during the treatment period. The plasma levels of ANP tended to increase, but those of aldosterone did not change with barnidipine. CONCLUSION: Barnidipine administration for a week decreased the blood pressure and made the sodium balance negative by increasing the urinary sodium excretion in patients with essential hypertension. The natriuretic effect of this drug could contribute at least in part to its antihypertensive effect.
Y Ohya; I Abe; Y Ohta; U Onaka; K Fujii; S Kagiyama; Y Fujishima-Nakao; M Fujishima
Related Documents :
3475419 - Blood pressure regulation on low and high sodium diets in normotensive members of normo...
3017159 - Experimental amitriptyline intoxication: treatment of cardiac toxicity with sodium bica...
6681039 - Relation of blood pressure with body and plasma electrolytes in conn's syndrome.
21817209 - Superconductivity up to 29 k in srfe(2)as(2) and bafe(2)as(2) at high pressures.
8141149 - Dietary calcium supplementation, blood pressure, and intestinal calcium absorption.
7403339 - 16, 16 dimethyl pge2: evidence that it has properties different from the parent compoun...
15012659 - Blood pool scintigraphy of the skull in relation to head-down tilt provocation in patie...
15560259 - The hemolymph of caterpillars spodoptera littoralis: physico-chemical properties and io...
104549 - Blood-brain barrier opening by isotonic saline infusion in normotensive and hypertensiv...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacology and therapeutics     Volume:  38     ISSN:  0946-1965     ISO Abbreviation:  Int J Clin Pharmacol Ther     Publication Date:  2000 Jun 
Date Detail:
Created Date:  2000-10-19     Completed Date:  2000-10-19     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  9423309     Medline TA:  Int J Clin Pharmacol Ther     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  304-8     Citation Subset:  IM    
Second Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Calcium Channel Blockers / pharmacology*
Hypertension / drug therapy*,  urine
Middle Aged
Natriuresis / drug effects*
Nifedipine / analogs & derivatives*,  pharmacology,  therapeutic use
Single-Blind Method
Reg. No./Substance:
0/Calcium Channel Blockers; 104713-75-9/mepirodipine; 21829-25-4/Nifedipine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Pharmacokinetics of cerivastatin when administered under fasted and fed conditions in the morning or...
Next Document:  Relative bioavailability study of two nifedipine tablet formulations in healthy male volunteers.